Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 30,2026 No.5 Detail

Retrospective study on the efficacy of insulin degludec/insulin aspart combined with dietary management in patients with type 2 diabetes mellitus

Published on Jun. 12, 2026Total Views: 133 times Total Downloads: 30 times Download Mobile

Author: XIANG Yuyang XIE Yuye LIN Zhihao

Affiliation: Department of Endocrinology, Wenzhou Traditional Chinese Medicine Hospital, Wenzhou 325000, Zhejiang Province, China

Keywords: Type 2 diabetes mellitus Insulin degludec/insulin aspart Integrated diet management model Efficacy observation

DOI: 10.12173/j.issn.2097-4922.202504007

Reference: XIANG Yuyang, XIE Yuye, LIN Zhihao.Retrospective study on the efficacy of insulin degludec/insulin aspart combined with dietary management in patients with type 2 diabetes mellitus[J]. Yaoxue QianYan Zazhi, 2026, 30(5): 813 - 819. DOI: 10.12173/j.issn.2097-4922.202504007[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To investigate the effects of insulin degludec/insulin aspart (IDegAsp) combined with an integrated diet management model (IDMM) on blood glucose control, lipid metabolism, health behaviors, self-management ability, and quality of life in patients with type 2 diabetes mellitus (T2DM).

Methods  Clinical data of T2DM patients diagnosed and treated in the Endocrinology Department of Wenzhou Traditional Chinese Medicine Hospital from January 2023 to June 2024 were retrospectively collected. Based on whether IDMM was adopted, the patients were divided into an IDegAsp group and an IDegAsp combined with IDMM group (IDegAsp-IDMM group). After 12 weeks of intervention, the blood glucose control indicators, the blood lipid metabolism indicators, health promoting lifestyle profile-II (HPLP-II) score, summary of diabetes self-care activities scale (SDSCA) score, and adjusted diabetes quality of life scale (A-DQOL) score of the two groups of patients were compared.

Results  A total of T2DM 107 patients were included, including 57 in the IDegAsp group and 50 in the IDegAsp-IDMM group. After intervention, in terms of blood glucose control indicators, fasting C-peptide, 2-hour post-meal C-peptide, fasting blood glucose, 2-hour post-meal blood glucose, and glycated hemoglobin in the IDegAsp-IDMM group were significantly lower than those in the IDegAsp group (P < 0.05). In terms of lipid metabolism indicators, HDL in T2DM patients in the IDegAsp-IDMM group was significantly higher than that in the IDegAsp group, while TG, LDL, and TC were significantly lower than those in the IDegAsp group (P < 0.05). In terms of scale scores, the HPLP-II scores and SDSCA scores of T2DM patients in the IDegAsp-IDMM group were significantly higher than those in the IDegAsp group, while the A-DQOL score was significantly lower than that in the IDegAsp group (P < 0.05).

Conclusion  The overall efficacy of IDegAsp-IDMM is better than that of IDegAsp alone, and it can improve glycolipid metabolism, health behaviors, self - management ability, and quality of life in T2DM patients.

Full-text
Please download the PDF version to read the full text: download
References

1. Yusufi FNK, Ahmed A, Ahmad J, et al. Impact of type 2 diabetes mellitus with a focus on Asian Indians living in India and Abroad: a systematic review[J] . Endocr Metab Immune Disord Drug Targets, 2023, 23(5): 609-616. DOI: 10.2174/1871530322666220 827161236.

2. 魏金凤 , 魏晓涛 , 张新丽 , 等 . 肠道菌群失衡与糖尿病肾病的关系及中药防治研究进展 [J]. 数理医药学杂志 , 2024, 37(5): 371-377. [Wei JF, Wei XT, Zhang XL, et al. Research progress of the relationship between intestinal flora imbalance and diabetic nephropathy and its prevention and treatment by traditional Chinese medicine[J]. Journal of Mathematical Medicine, 2024, 37(5): 371-377.] DOI: 10.12173/j.issn.1004-4337.202312024.

3. 梅佳, 吴美璇, 胡泽林, 等. 糖尿病患者视网膜病变危险因素的Meta分析[J]. 数理医药学杂志, 2024, 37(5): 360-370. [Mei J, Wu MX, Hu ZL, et al. The risk factors of retinopathy in diabetes patients: a Meta-analysis[J]. Journal of Mathematical Medicine, 2024, 37(5): 360-370. ] DOI: 10.12173/ j.issn.1004-4337.202401075.

4. 肖国庆 , 康学东 , 易希善 . 糖尿病致动脉粥样硬化的相关途径及中西医治疗进展[J]. 数理医药学杂志, 2023, 36(4): 307-315. [Xiao GQ, Kang XD, Yi XS. Related pathways of diabetes-induced atherosclerosis and research progress of traditional Chinese and western medicine treatment[J]. Journal of Mathematical Medicine, 2023, 36(4): 307-315. ] DOI: 10.12173/ j.issn.1004-5511.202301059.

5. 朱大龙, 赵维纲, 匡洪宇, 等. 德谷门冬双胰岛素临床应用专家指导意见[J]. 中华糖尿病杂志, 2021, 13(7): 695-701. [Zhu DL, Zhao WG, Kuang HY, et al. Expert consensus on clinical application of insulin degludec/insulin aspart[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(7): 695-701.] DOI: 10.3760/cma.j.cn115791-20210506-00247.

6. 温敬冬 , 岳小林 , 杨旻星, 等. 儿童和青少年 2 型糖尿病患者饮食管理的最佳证据总结 [J]. 护理学杂志 , 2025, 40(1): 99- 104, 110. [Wen JD, Yue XL, Yang MX, et al. Summary of best evidence for diet management in children and adolescents with type 2 diabetes mellitus[J]. Journal of Nursing Science, 2025, 40(1): 99- 104, 110. ] DOI: 10.3870/j.issn.1001-4152.2025.01.099.

7. 陈丽彬, 梁晓珊, 林佳清, 等. 健康饮食指导在糖尿病高血压患者护理中的应用效果及满意度分析 [J]. 心血管病防治知识 , 2022, 12(6): 23-25. [Chen LB, Liang XS, Lin JQ, et al. Application effect and satisfaction analysis of healthy diet guidance in nursing care of diabetic hypertensive patients[J]. Knowledge of Cardiovascular Disease Prevention and Treatment, 2022, 12(6): 23-25.] DOI: 10.3969/j.issn.1672-3015(x).2022.06.007.

8. 中华医学会糖尿病学分会 . 中国糖尿病防治指南(2024 版)[J].中华糖尿病杂志 , 2025, 17(1): 16-139. [Chinese Diabetes Society. Chinese guidelines for the prevention and treatment of diabetes (2024 edition)[J]. Chinese Journal of Diabetes, 2025, 17(1): 16-139. ] DOI: 10.3760/cma.j.cn115791-20241203-00705

9. 中国营养学会 , 编 . 中国居民膳食指南(2022)[M]. 北京:人民卫生出版社 , 2022: 9-136.

10. 中国医疗保健国际交流促进会营养与代谢管理分会 , 中国营养学会临床营养分会 , 中华医学会糖尿病学分会 , 等 . 中国糖尿病医学营养治疗指南(2022 版)[J]. 中华糖尿病杂志 , 2022, 14(9): 881-933. [China International Exchange Association for Medical Care Nutrition and Metabolism Management Branch, Clinical Nutrition Branch of Chinese Nutrition Society, Chinese Diabetes Society, et al. Chinese guidelines for medical nutrition therapy of diabetes (2022 edition)[J]. Chinese Journal of Diabetes, 2022, 14(9): 881-933. ] DOI: 10.3760/cma.j.cn115791- 20220704-00324.

11. 于明明, 王昀莛, 刘萍. 一体化延伸护理在2型糖尿病患者中的应用及对血糖控制效果、自我管理能力的影响[J]. 糖尿病新世界, 2024, 27(2): 149-153. [Yu MM, Wang YT, Liu P. Application of integrated extended care in type 2 diabetes patients and its effect on blood glucose control and self-management ability[J]. Diabetes New World, 2024, 27(2): 149-153. ] DOI: 10.16658/j.cnki.1672-4062.2024.02.149.

12. 廖冬兰, 黄彩艳, 苏美基. 递进式目标管理结合专病一体化饮食指导在 2 型糖尿病患者中的应用效果 [J]. 中西医结合护理(中英文), 2023, 9(3): 21-24. [Liao DL, Huang CY, Su MJ. Application effect of progressive goal management combined with specialized integrated diet guidance in type 2 diabetes patients[J]. Journal of Clinical Nursing in Practice, 2023, 9(3): 21-24.] DOI: 10.11997/nitcwm.202303006.

13. 施新艳, 朱瑜, 姜丽. 多学科协作量化管理一体化护理模式在糖尿病合并冠心病患者护理中的应用 [J]. 齐鲁护理杂志, 2022, 28(7): 109-112. [Shi XY, Zhu Y, Jiang L. Application of multidisciplinary collaborative quantitative management integrated nursing model in nursing care of patients with diabetes mellitus complicated with coronary heart disease[J]. Journal of Qilu Nursing, 2022, 28(7): 109-112. ] DOI: 10.3969/j.issn.1006-7256.2022.07.035

14. 闫海鸽. 医院-社区-家庭一体化饮食护理干预对 2 型糖尿病患者自我管理能力及血糖稳定性的影响 [J]. 中国社区医师 , 2021, 37(12): 170-171. [Yan HG. Effect of hospital-community- family integrated diet nursing intervention on self-management ability and blood glucose stability in type 2 diabetes patients[J]. Chinese Community Doctors, 2021, 37(12): 170-171.] DOI: 10.3969/j.issn.1007-614x.2021.12.082.

15. 蓝玉丽, 严清梅, 杨志敏. 对2型糖尿病患者进行医院-社区-家庭一体化护理管理的效果研究 [J]. 当代医药论丛, 2019, 17(20): 194-195. [Lan YL, Yan QM, Yang ZM. Effect study on hospital-community-family integrated nursing management for type 2 diabetes patients[J]. Contemporary Medical Symposium, 2019, 17(20): 194-195.] https://d.wanfangdata.com.cn/periodical/ ChtQZXJpb2RpY2FsQ0hJMjAyNTA2MTcxNjU3NTMSD2RkeXls YzIwMTkyMDE0NBoIY3Q0Y2pmY3A%3D.

16. 刘珍, 郑海兰, 江斓, 等. 德谷门冬双胰岛素和门冬胰岛素30治疗 2 型糖尿病非肥胖型患者的临床研究 [J]. 中国临床药理学杂志 , 2024, 40(12): 1714-1717. [Liu Z, Zheng HL, Jiang L, et al. Clinical study of insulin degludec/insulin aspart and insulin aspart 30 in the treatment of non-obese type 2 diabetes mellitus patients[J]. The Chinese Journal of Clinical Pharmacology, 2024, 40(12): 1714- 1717.] DOI: 10.13699/j.cnki.1001-6821.2024.12.004.

17. 宋洁, 王文平, 丁晓洁, 等. 瑞舒伐他汀对老年2型糖尿病脂 代 谢 紊 乱 患 者 血 脂、Hcy、hs-CRP的影响[J]. 安徽医药, 2015, 19(5): 997-999. [Song J, Wang WP, Ding XJ, et al. Effect of rosuvastatin on blood lipids, Hcy and hs-CRP in elderly type 2 diabetes mellitus patients with lipid metabolism disorder[J]. Anhui Medical and Pharmaceutical Journal, 2015, 19(5): 997-999.] DOI: 10.3969/j.issn.1009-6469.2015.05.058.

Popular papers
Last 6 months